Form 4 for BGMS Bio Green Med Solution, Inc.
Accepted 2022-06-16 00:00:00 ET · period of report 2022-06-14 · accession 0001104659-22-071900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-16 | 2022-06-14 | BGMS | Spiegel Robert J. | Dir | A - Grant | $0.00 | +15.8K | 18.2K | +666% | $0 |
| D | 2022-06-16 | 2022-06-14 | BGMS | Spiegel Robert J. | Dir | A - Grant | $0.00 | +31.6K | 31.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-14 | A | A | 15,822 | $0.00 | 18,196 | D | — | — | (F1) The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023. |
| 2 | Derivative | Stock Option (right to buy) | 2022-06-14 | A | A | 31,645 | $0.00 | 31,645 | D | $1.11 · 2023-06-14 to 2032-06-14 | 31,645 Common Stock | (F2) These options were granted to Dr. Spiegel for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. |